Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Arix to Present at the Jefferies Virtual London Healthcare Conference
Arix to Present at the Jefferies Virtual London Healthcare Conference
Arix to Present at the Jefferies Virtual London Healthcare Conference
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Form 8.3 - The Vanguard Group, Inc.: RSA Insurnace Group plc
Hardman & Co Research: Arix Bioscience (ARIX): Hitting the jackpot
Hardman & Co Research: Arix Bioscience (ARIX): Hitting the jackpot
Hardman & Co Research: Arix Bioscience (ARIX): Hitting the jackpot
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Hardman & Co Research: Non-Standard Finance Plc (NSF): 1H'20 results:
Hardman & Co Research: Non-Standard Finance Plc (NSF): 1H'20 results:
Hardman & Co Research: Non-Standard Finance Plc (NSF): 1H'20 results:
Arix Bioscience PLC: VelosBio to be acquired by Merck for $2.75 billion
Arix Bioscience PLC: VelosBio to be acquired by Merck for $2.75 billion
Arix Bioscience PLC: VelosBio to be acquired by Merck for $2.75 billion
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC